JSES reviews, reports, and techniques | 2024 | Secci G, Schippers P, Biégun M, Mouchantaf M
Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.
15. Am J Sports Med. 2016 Dec;44(12):3270-3283. doi: 10.1177/0363546516634674. Epub 2016 Mar 29. Biologic Treatments for Sports Injuries II Think Tank-Current Concepts, Future Research, and Barriers to Advancement, Part 1: Biologics Overview, Ligament Injury, Tendinopathy. LaPrade RF(1), Geeslin AG(2), Murray IR(3), Musahl V(4), Zlotnicki JP(4), Petrigliano F(5), Mann BJ(6)(7). Author information: (1)Steadman Philippon Research Institute, Vail, Colorado, USA drlaprade@sprivail.org. (2)Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, USA. (3)University of Edinburgh, Edinburgh, UK. (4)University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. (5)University of California, Los Angeles, California, USA. (6)Author deceased. (7)American Orthopaedic Society for Sports Medicine, Rosemont, Illinois, USA. Biologic therapies, including stem cells, platelet-rich plasma, growth factors, and other biologically active adjuncts, have recently received increased attention in the basic science and clinical literature. At the 2015 AOSSM Biologics II Think Tank held in Colorado Springs, Colorado, a group of orthopaedic surgeons, basic scientists, veterinarians, and other investigators gathered to review the state of the science for biologics and barriers to implementation of biologics for the treatment of sports medicine injuries. This series of current concepts reviews reports the summary of the scientific presentations, roundtable discussions, and recommendations from this think tank. © 2016 The Author(s). DOI: 10.1177/0363546516634674
This article has not been linked to a wiki topic yet.
This article has not been linked to a case yet.
This article has not been linked to an atlas yet.